MGS today announced its acquisition of Denmark-based injection molder Knudsen Plast A/S, an organization with more than four decades of healthcare manufacturing experience. Neither company disclosed the deal’s terms.

With operations in both Denmark and Slovakia, the deal enhances MGS’ ability to support customer needs across Europe with expanded cleanroom capacity, deep injection molding expertise, and greater proximity to fast-growing regional supply chains.

“This acquisition is beneficial for both MGS and Knudsen Plast customers,” MGS CEO Paul Manley said. “MGS benefits from Knudsen Plast’s technical expertise, strong quality systems, and a commitment to delivering innovations that improve lives. At the same time, Knudsen Plast customers benefit from MGS’ vertically integrated solutions across design and development, tooling, automation, and manufacturing. Together, we are better positioned to help healthcare innovators accelerate development, strengthen supply chains, and scale production with confidence.”

Across its facilities, Knudsen Plast is recognized for delivering innovative, high-quality solutions that not only meet but help shape rigorous quality standards alongside its customers.

“Joining MGS is a natural next step for our team and our customers,” Knudsen Plast Managing Director Jens Kristian Pedersen stated. “We are both committed to advancing healthcare innovations, and have cultures built on responsibility, precision, and trust.”

MGS now employs 1,600 team members across 13 global facilities, strengthening its ability to provide end-to-end healthcare development and manufacturing solutions. This includes:

• Expanded cleanroom molding capacity in Europe.
• Enhanced regional supply chain resilience.
• Increased access to healthcare-focused molding expertise.
• New career and development opportunities for employees across Knudson Plast and MGS.

“This relationship opens new opportunities to bring greater value to pharma, diagnostic, and medtech companies in Central and Eastern Europe, while giving our employees an enhanced ability to grow within a global organization,” Knudsen Plast Slovakia Managing Director Soren Nielsen added.

MGS is a global end-to-end healthcare contract development and manufacturing organization (CDMO) offering a complete healthcare value chain solution. Headquartered in Germantown, Wis., MGS provides vertically integrated capabilities including medical product design and development, high-cavitation complex tooling, healthcare automation solutions, and high-volume precision manufacturing across 13 global locations.

Knudsen Plast is a partner for injection-molded medical devices, operating ISO 13485-certified facilities with ISO Class 7 and Class 8 cleanroom capacity. With more than 200 employees and specialized operations in Denmark and Slovakia, the company supports healthcare customers with product maturation, production ramp-up, and high-quality volume manufacturing.